Furthermore, co-activation of S1PR1 and STAT3 was observed in ABC-DLBCL cells and tissues, and S1PR1 was suggested as a potential target for blocking STAT3 activation [18]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.